Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab

Sarcopenia is a muscle loss syndrome known as a risk factor of various carcinomas. The impact of sarcopenia and sarcopenia-related inflammatory/nutritional markers in metastatic urothelial carcinoma (mUC) treated with pembrolizumab was unknown, so this retrospective study of 27 patients was performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Takuto, Miyake, Makito, Hori, Shunta, Ichikawa, Kazuki, Omori, Chihiro, Iemura, Yusuke, Owari, Takuya, Itami, Yoshitaka, Nakai, Yasushi, Anai, Satoshi, Tomioka, Atsushi, Tanaka, Nobumichi, Fujimoto, Kiyohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277993/
https://www.ncbi.nlm.nih.gov/pubmed/32429323
http://dx.doi.org/10.3390/diagnostics10050310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277993/
https://www.ncbi.nlm.nih.gov/pubmed/32429323
http://dx.doi.org/10.3390/diagnostics10050310

Ejemplares similares